122 related articles for article (PubMed ID: 26631052)
1. Cadmium Levels in Tissue and Plasma as a Risk Factor for Prostate Carcinoma: a Meta-Analysis.
Zhang L; Zhu Y; Hao R; Shao M; Luo Y
Biol Trace Elem Res; 2016 Jul; 172(1):86-92. PubMed ID: 26631052
[TBL] [Abstract][Full Text] [Related]
2. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
[TBL] [Abstract][Full Text] [Related]
3. Cadmium burden and the risk and phenotype of prostate cancer.
Chen YC; Pu YS; Wu HC; Wu TT; Lai MK; Yang CY; Sung FC
BMC Cancer; 2009 Dec; 9():429. PubMed ID: 20003241
[TBL] [Abstract][Full Text] [Related]
4. Elevated Serum and Hair Levels of Cadmium as a Risk Factor for Liver Carcinoma: A Meta-Analysis.
Zhang L; Wang Y; Li T; Zhuo W; Zhu Y
Nutr Cancer; 2023; 75(6):1438-1447. PubMed ID: 37203428
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis links autism and toxic metals and highlights the impact of country development status: Higher blood and erythrocyte levels for mercury and lead, and higher hair antimony, cadmium, lead, and mercury.
Saghazadeh A; Rezaei N
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):340-368. PubMed ID: 28716727
[TBL] [Abstract][Full Text] [Related]
6. Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
Xu L; Zhang W; Liu X; Zhang C; Wang P; Zhao X
J Alzheimers Dis; 2018; 62(1):361-372. PubMed ID: 29439342
[TBL] [Abstract][Full Text] [Related]
7. [Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer].
Daragó A; Sapota A; Duda-Szymańska J
Rocz Panstw Zakl Hig; 2003; 54 Suppl():39-40. PubMed ID: 12884501
[No Abstract] [Full Text] [Related]
8. Prostate cancer outcome and tissue levels of metal ions.
Sarafanov AG; Todorov TI; Centeno JA; Macias V; Gao W; Liang WM; Beam C; Gray MA; Kajdacsy-Balla AA
Prostate; 2011 Aug; 71(11):1231-8. PubMed ID: 21271612
[TBL] [Abstract][Full Text] [Related]
9. High cadmium / zinc ratio in cigarette smokers: potential implications as a biomarker of risk of prostate cancer.
Anetor JI; Ajose F; Anetor GO; Iyanda AA; Babalola OO; Adeniyi FA
Niger J Physiol Sci; 2008; 23(1-2):41-9. PubMed ID: 19434213
[TBL] [Abstract][Full Text] [Related]
10. Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans.
Lee JD; Wu SM; Lu LY; Yang YT; Jeng SY
J Formos Med Assoc; 2009 Jul; 108(7):554-9. PubMed ID: 19586829
[TBL] [Abstract][Full Text] [Related]
11. Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups.
Gray MA; Centeno JA; Slaney DP; Ejnik JW; Todorov T; Nacey JN
Int J Environ Res Public Health; 2005 Dec; 2(3-4):374-84. PubMed ID: 16819092
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of toenail cadmium and prostate cancer risk in Italy.
Vinceti M; Venturelli M; Sighinolfi C; Trerotoli P; Bonvicini F; Ferrari A; Bianchi G; Serio G; Bergomi M; Vivoli G
Sci Total Environ; 2007 Feb; 373(1):77-81. PubMed ID: 17175009
[TBL] [Abstract][Full Text] [Related]
13. The role of circulating adiponectin in prostate cancer: a meta-analysis.
Liao Q; Long C; Deng Z; Bi X; Hu J
Int J Biol Markers; 2015 Feb; 30(1):e22-31. PubMed ID: 25450645
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies.
YuPeng L; YuXue Z; PengFei L; Cheng C; YaShuang Z; DaPeng L; Chen D
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1086-93. PubMed ID: 25953767
[TBL] [Abstract][Full Text] [Related]
15. Cadmium and prostate cancer.
Waalkes MP; Rehm S
J Toxicol Environ Health; 1994 Nov; 43(3):251-69. PubMed ID: 7966437
[TBL] [Abstract][Full Text] [Related]
16. Exposure to cadmium and head and neck cancers: a meta-analysis of observational studies.
Rezapour M; Rezapour HA; Chegeni M; Khanjani N
Rev Environ Health; 2021 Dec; 36(4):577-584. PubMed ID: 33544537
[TBL] [Abstract][Full Text] [Related]
17. Cadmium exposure and prostate cancer: insights, mechanisms and perspectives.
Rapisarda V; Miozzi E; Loreto C; Matera S; Fenga C; Avola R; Ledda C
Front Biosci (Landmark Ed); 2018 Mar; 23(9):1687-1700. PubMed ID: 29293457
[TBL] [Abstract][Full Text] [Related]
18. Urinary cadmium concentration and risk of breast cancer: a systematic review and dose-response meta-analysis.
Larsson SC; Orsini N; Wolk A
Am J Epidemiol; 2015 Sep; 182(5):375-80. PubMed ID: 26254432
[TBL] [Abstract][Full Text] [Related]
19. Zinc and cadmium analysis in human prostate neoplasms.
Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial interventions for men with prostate cancer.
Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
